Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

177-Lu JH 020002

Next Previous
Drug Profile

177-Lu JH 020002

Alternative Names: 177-Lu-JH020002

Latest Information Update: 04 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bivision Pharmaceuticals
  • Class Antineoplastics; Drug conjugates; Radioisotopes; Radiopharmaceuticals
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Prostate cancer

Most Recent Events

  • 30 May 2025 Efficacy and adverse events data from a phase I/II trial in Prostrate cancer presented at the 61st Annual Meeting of the American Society of Clinical Oncology (ASCO-2025)
  • 22 Dec 2023 Phase-I/II clinical trials in Prostate cancer (Late-stage disease) in China (IV) (NCT06139575)
  • 18 Nov 2023 Bivision Pharmaceuticals plans a phase I/II trial for Prostate Cancer (Late-stage disease, Metastatic disease) in December 2023 (NCT06139575)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top